Project description
3D materials for treating musculoskeletal defects in immunocompromised patients
The immune system not only plays a crucial role in fighting pathogens, but it is also vital for the physiological healing of damaged tissues. Patients with chronic diseases such as diabetes present with a compromised immune system and reduced wound healing capacity. The scope of the EU-funded ImmunoBioInks project is to develop 3D-printed materials to treat musculoskeletal defects in patients with an immune system imbalance. The idea is to combine peptides, hyaluronic acid and nanomaterials into printable scaffolds of defined architecture and with carefully designed mechanical properties that can reprogram the patient’s own immune cells. The interaction of immune cells with this innovative 3D scaffold is expected to trigger the necessary healing response.
Fields of science
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesbasic medicineimmunology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- engineering and technologymechanical engineeringmanufacturing engineeringadditive manufacturing
Programme(s)
Funding Scheme
MSCA-IF-EF-ST - Standard EFCoordinator
7270 Davos Platz
Switzerland
See on map